Samsung Biologics Co.,Ltd.
KR ˙ KOSE ˙ KR7207940008
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT
SecurityKR:A207940 / Samsung Biologics Co.,Ltd.
InstitutionKorea Fund Inc
Latest Disclosed Ownership4,310 shares
Latest Disclosed Value $ 3,162,754
Korea Fund Inc reports 1.89% increase in ownership of A207940 / Samsung Biologics Co.,Ltd.

On August 22, 2025 - Korea Fund Inc filed a NPORT-P form disclosing ownership of 4,310 shares of Samsung Biologics Co.,Ltd. (KR:A207940) valued at $3,162,754 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 21, 2025 disclosing 4,230 shares of Samsung Biologics Co.,Ltd.. This represents a change in shares of 1.89% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-22 2025-06-30 NP Samsung Biologics Co. EC KR7207940008 4,310 80 1.89 3,163 7.73 2.4641
2025-05-21 2025-03-31 NP Samsung Biologics Co. EC KR7207940008 4,230 180 4.44 2,936 13.10 2.9809
2025-02-25 2024-12-31 NP Samsung Biologics Co. EC KR7207940008 4,050 -250 -5.81 2,595 -18.86 2.8540
2024-11-26 2024-09-30 NP Samsung Biologics Co. EC KR7207940008 4,300 -1,150 -21.10 3,198 11.51 2.7645
2024-08-23 2024-06-30 NP Samsung Biologics Co. EC KR7207940008 5,450 0 0.00 2,868 -14.97 2.0617
2024-05-24 2024-03-31 NP Samsung Biologics Co. EC KR7207940008 5,450 0 0.00 3,373 5.21 2.3970
2024-02-27 2023-12-31 NP Samsung Biologics Co. EC KR7207940008 5,450 250 4.81 3,206 22.18 2.3170
2023-11-27 2023-09-30 NP Samsung Biologics Co. EC KR7207940008 5,200 200 4.00 2,625 -7.28 2.1317
2023-08-22 2023-06-30 NP Samsung Biologics Co. EC KR7207940008 5,000 100 2.04 2,831 -4.71 2.1656
2023-05-24 2023-03-31 NP Samsung Biologics Co. EC KR7207940008 4,900 -1,060 -17.79 2,970 -23.35 2.2939
2023-02-24 2022-12-31 NP Samsung Biologics Co. EC KR7207940008 5,960 0 0.00 3,875 16.16 3.1536
2022-11-22 2022-09-30 NP Samsung Biologics Co. EC KR7207940008 5,960 -110 -1.81 3,336 -10.08 2.9000
2022-08-23 2022-06-30 NP Samsung Biologics Co. EC KR7207940008 6,070 70 1.17 3,711 -8.98 2.5987
2022-05-23 2022-03-31 NP Samsung Biologics Co. EC KR7207940008 6,000 -1,534 -20.36 4,077 -28.74 2.2412
2022-02-25 2021-12-31 NP Samsung Biologics Co. EC KR7207940008 7,534 304 4.20 5,721 7.82 2.8896
2021-11-22 2021-09-30 NP Samsung Biologics Co. EC KR7207940008 7,230 180 2.55 5,305 1.01 2.2152
2021-08-26 2021-06-30 NP Samsung Biologics Co. EC KR7207940008 7,050 250 3.68 5,253 16.04 1.9245
2021-05-20 2021-03-31 NP Samsung Biologics Co. EC KR7207940008 6,800 4,902 258.27 4,526 213.22 1.8048
2021-02-05 2020-12-31 NP Samsung Biologics EC KR7207940008 1,898 0 0.00 1,445 29.25 0.6113
2020-11-24 2020-09-30 NP Samsung Biologics EC KR7207940008 1,898 1,052 124.35 1,119 104.01 0.6311
2020-08-05 2020-06-30 NP Samsung Biologics EC KR7207940008 846 846 549 0.3502
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.